Albuterol
Who holds supplier records for Albuterol? 3 organisations hold a current record for Albuterol: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (1); not recorded for 2.
Most records are filed under another form of this substance: Albuterol Sulfate (12 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Albuterol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/albuterol
Reading the evidence
- 3 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (3)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Albuterol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- GLAXOSMITHKLINE LLCActive DMF 25189 · latest filing Dec 2011
- Neuland Laboratories LimitedIndiaActive DMF 16104 · latest filing Aug 2002
- PEARL THERAPEUTICS INCActive DMF 31995 · latest filing Oct 2017
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Albuterol are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Amphastar Nanjing PharmaceuticalsChina · Inactive DMF 31034 · filed Dec 2016
- India · Inactive DMF 6886 · filed Jan 1987
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (41 listed products contain Albuterol). The latest listed exclusivity runs to 19 Dec 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Albuterol is a bronchodilator that relaxes muscles in the airways and increases airflow to the lungs. It is used to treat or prevent bronchospasm in people with reversible obstructive airway disease.
Chemical identity
- IUPAC name
- 4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol
- Canonical SMILES
- CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
- InChIKey
- NDAUXUAQIAJITI-UHFFFAOYSA-N
- Synonyms
- etinoline, nsc-757417, salbutamol, salbutamolum, sch 13949w, sch-13949w, ventoline
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Albuterol?
3 organisations hold an active US FDA Type II Drug Master File or a CEP for Albuterol: GLAXOSMITHKLINE LLC, Neuland Laboratories Limited (India) and PEARL THERAPEUTICS INC. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Albuterol Drug Master Files are active?
GLAXOSMITHKLINE LLC (DMF 25189), Neuland Laboratories Limited (DMF 16104) and PEARL THERAPEUTICS INC (DMF 31995). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Albuterol records mean?
2 organisations have only inactive Type II DMFs for Albuterol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Albuterol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Albuterol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.